Utilization Management Gets an AI Test Run

MedeAnalytics and Basys.ai aim to automate routine approvals, showing how insurers are cautiously testing AI in one of healthcare’s most disputed workflows

16 Dec 2025

Few corners of America’s healthcare system attract as much ire as utilisation management. The process that decides whether care is approved, delayed or denied is blamed for slowing treatment and drowning clinicians in paperwork. It is now becoming a proving ground for artificial intelligence.

MedeAnalytics and Basys.ai have announced a partnership to embed AI into utilisation-management workflows. The aim is modest but pointed. Rather than replacing clinical judgement, the firms want software to speed decisions governed by clear rules. For insurers, providers and patients alike, the move signals that automation is pushing into an area long resistant to reform.

Utilisation management sits uneasily between cost control and access to care. Insurers depend on it to restrain spending. Providers argue it creates bottlenecks that leave patients waiting. As medical costs climb and regulators scrutinise approval practices more closely, payers face pressure to show they can act faster without sacrificing safeguards.

MedeAnalytics brings experience handling vast stores of claims, clinical and financial data from health plans across the country. Basys.ai contributes tools built to automate tasks such as prior-authorisation checks and reviews of medical records. Combined, the companies argue, AI systems can clear straightforward cases quickly, allowing staff to concentrate on complex or sensitive decisions.

Executives stress that humans will remain in the loop. Under the proposed model, software reviews information and fast-tracks routine requests, while edge cases are escalated to people. This division reflects persistent worries about transparency, accountability and compliance as automation spreads through healthcare administration.

Observers see the tie-up as part of a wider shift. Health plans are moving beyond analytics and dashboards towards embedding AI in daily operations. Staffing shortages and rising administrative costs are strong incentives. Utilisation management stands out because even small gains in speed or accuracy could have visible effects across the system.

The promise is quicker approvals, shorter backlogs and smoother access to care. The danger is a loss of trust if decisions appear opaque or unfair. For now, the MedeAnalytics and Basys.ai partnership is less a verdict than a signal. Insurers are cautiously testing whether AI can ease one of healthcare’s most contentious choke points without making it worse.